Search

everythinglearnresearchcommunity

for

Search:↓

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Hair follicles in mice help detect and respond to germs.

Porcine skin is very similar to human skin, making it a useful model for research.

Angelica sinensis helps repair and regenerate the thymus in mice.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

taVNS reduces vitiligo symptoms in mice.

Stress keratins are expressed less in diseased skin and are linked to differentiation, inflammation, and immunity.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

The scalp's microorganisms significantly affect hair health and disease.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Entospletinib effectively prevents eye and skin GVHD in mice.

Targeting macrophages may improve wound healing.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Enterococcus faecalis delays wound healing by disrupting cell functions and creating an anti-inflammatory environment.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Similar treatments might work for different types of scarring hair loss.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.